Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus

This study has been terminated.
(The study was terminated prematurely on 16 May 2014 due to a safety concern.)
Information provided by (Responsible Party):
Pfizer Identifier:
First received: December 20, 2012
Last updated: July 2, 2014
Last verified: July 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)